IgA Nephropathy Drugs Market, Global Outlook and Forecast 2022-2028

Code: RW00014789765
Market Monitor Global
Aug-2022
Life Sciences
64 Pages

IgA nephropathy, also known as Berger's disease, is?a kidney disease that occurs when IgA deposits build up in the kidneys, causing inflammation that damages kidney tissues. IgA is an antibody-a protein made by the immune system to protect the body from foreign substances such as bacteria or viruses.
This report contains market size and forecasts of IgA Nephropathy Drugs in Global, including the following market information:
Global IgA Nephropathy Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global IgA Nephropathy Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Phase I Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of IgA Nephropathy Drugs include Calliditas Therapeutics, Travere Therapeutics, Omeros Corporation, Novartis International, Chinook Therapeutics, Vera Therapeutics and Otsuka Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Publisher has surveyed the IgA Nephropathy Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global IgA Nephropathy Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global IgA Nephropathy Drugs Market Segment Percentages, by Type, 2021 (%)
Phase I
Phase II
Phase III
Global IgA Nephropathy Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global IgA Nephropathy Drugs Market Segment Percentages, by Application, 2021 (%)
Clinical Treatment
Drug Experiment
Global IgA Nephropathy Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global IgA Nephropathy Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies IgA Nephropathy Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies IgA Nephropathy Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Calliditas Therapeutics
Travere Therapeutics
Omeros Corporation
Novartis International
Chinook Therapeutics
Vera Therapeutics
Otsuka Pharmaceutical

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 IgA Nephropathy Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global IgA Nephropathy Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global IgA Nephropathy Drugs Overall Market Size
2.1 Global IgA Nephropathy Drugs Market Size: 2021 VS 2028
2.2 Global IgA Nephropathy Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top IgA Nephropathy Drugs Players in Global Market
3.2 Top Global IgA Nephropathy Drugs Companies Ranked by Revenue
3.3 Global IgA Nephropathy Drugs Revenue by Companies
3.4 Top 3 and Top 5 IgA Nephropathy Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies IgA Nephropathy Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 IgA Nephropathy Drugs Players in Global Market
3.6.1 List of Global Tier 1 IgA Nephropathy Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 IgA Nephropathy Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global IgA Nephropathy Drugs Market Size Markets, 2021 & 2028
4.1.2 Phase I
4.1.3 Phase II
4.1.4 Phase III
4.2 By Type - Global IgA Nephropathy Drugs Revenue & Forecasts
4.2.1 By Type - Global IgA Nephropathy Drugs Revenue, 2017-2022
4.2.2 By Type - Global IgA Nephropathy Drugs Revenue, 2023-2028
4.2.3 By Type - Global IgA Nephropathy Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global IgA Nephropathy Drugs Market Size, 2021 & 2028
5.1.2 Clinical Treatment
5.1.3 Drug Experiment
5.2 By Application - Global IgA Nephropathy Drugs Revenue & Forecasts
5.2.1 By Application - Global IgA Nephropathy Drugs Revenue, 2017-2022
5.2.2 By Application - Global IgA Nephropathy Drugs Revenue, 2023-2028
5.2.3 By Application - Global IgA Nephropathy Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global IgA Nephropathy Drugs Market Size, 2021 & 2028
6.2 By Region - Global IgA Nephropathy Drugs Revenue & Forecasts
6.2.1 By Region - Global IgA Nephropathy Drugs Revenue, 2017-2022
6.2.2 By Region - Global IgA Nephropathy Drugs Revenue, 2023-2028
6.2.3 By Region - Global IgA Nephropathy Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America IgA Nephropathy Drugs Revenue, 2017-2028
6.3.2 US IgA Nephropathy Drugs Market Size, 2017-2028
6.3.3 Canada IgA Nephropathy Drugs Market Size, 2017-2028
6.3.4 Mexico IgA Nephropathy Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe IgA Nephropathy Drugs Revenue, 2017-2028
6.4.2 Germany IgA Nephropathy Drugs Market Size, 2017-2028
6.4.3 France IgA Nephropathy Drugs Market Size, 2017-2028
6.4.4 U.K. IgA Nephropathy Drugs Market Size, 2017-2028
6.4.5 Italy IgA Nephropathy Drugs Market Size, 2017-2028
6.4.6 Russia IgA Nephropathy Drugs Market Size, 2017-2028
6.4.7 Nordic Countries IgA Nephropathy Drugs Market Size, 2017-2028
6.4.8 Benelux IgA Nephropathy Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia IgA Nephropathy Drugs Revenue, 2017-2028
6.5.2 China IgA Nephropathy Drugs Market Size, 2017-2028
6.5.3 Japan IgA Nephropathy Drugs Market Size, 2017-2028
6.5.4 South Korea IgA Nephropathy Drugs Market Size, 2017-2028
6.5.5 Southeast Asia IgA Nephropathy Drugs Market Size, 2017-2028
6.5.6 India IgA Nephropathy Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America IgA Nephropathy Drugs Revenue, 2017-2028
6.6.2 Brazil IgA Nephropathy Drugs Market Size, 2017-2028
6.6.3 Argentina IgA Nephropathy Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa IgA Nephropathy Drugs Revenue, 2017-2028
6.7.2 Turkey IgA Nephropathy Drugs Market Size, 2017-2028
6.7.3 Israel IgA Nephropathy Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia IgA Nephropathy Drugs Market Size, 2017-2028
6.7.5 UAE IgA Nephropathy Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Calliditas Therapeutics
7.1.1 Calliditas Therapeutics Corporate Summary
7.1.2 Calliditas Therapeutics Business Overview
7.1.3 Calliditas Therapeutics IgA Nephropathy Drugs Major Product Offerings
7.1.4 Calliditas Therapeutics IgA Nephropathy Drugs Revenue in Global Market (2017-2022)
7.1.5 Calliditas Therapeutics Key News
7.2 Travere Therapeutics
7.2.1 Travere Therapeutics Corporate Summary
7.2.2 Travere Therapeutics Business Overview
7.2.3 Travere Therapeutics IgA Nephropathy Drugs Major Product Offerings
7.2.4 Travere Therapeutics IgA Nephropathy Drugs Revenue in Global Market (2017-2022)
7.2.5 Travere Therapeutics Key News
7.3 Omeros Corporation
7.3.1 Omeros Corporation Corporate Summary
7.3.2 Omeros Corporation Business Overview
7.3.3 Omeros Corporation IgA Nephropathy Drugs Major Product Offerings
7.3.4 Omeros Corporation IgA Nephropathy Drugs Revenue in Global Market (2017-2022)
7.3.5 Omeros Corporation Key News
7.4 Novartis International
7.4.1 Novartis International Corporate Summary
7.4.2 Novartis International Business Overview
7.4.3 Novartis International IgA Nephropathy Drugs Major Product Offerings
7.4.4 Novartis International IgA Nephropathy Drugs Revenue in Global Market (2017-2022)
7.4.5 Novartis International Key News
7.5 Chinook Therapeutics
7.5.1 Chinook Therapeutics Corporate Summary
7.5.2 Chinook Therapeutics Business Overview
7.5.3 Chinook Therapeutics IgA Nephropathy Drugs Major Product Offerings
7.5.4 Chinook Therapeutics IgA Nephropathy Drugs Revenue in Global Market (2017-2022)
7.5.5 Chinook Therapeutics Key News
7.6 Vera Therapeutics
7.6.1 Vera Therapeutics Corporate Summary
7.6.2 Vera Therapeutics Business Overview
7.6.3 Vera Therapeutics IgA Nephropathy Drugs Major Product Offerings
7.6.4 Vera Therapeutics IgA Nephropathy Drugs Revenue in Global Market (2017-2022)
7.6.5 Vera Therapeutics Key News
7.7 Otsuka Pharmaceutical
7.7.1 Otsuka Pharmaceutical Corporate Summary
7.7.2 Otsuka Pharmaceutical Business Overview
7.7.3 Otsuka Pharmaceutical IgA Nephropathy Drugs Major Product Offerings
7.7.4 Otsuka Pharmaceutical IgA Nephropathy Drugs Revenue in Global Market (2017-2022)
7.7.5 Otsuka Pharmaceutical Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. IgA Nephropathy Drugs Market Opportunities & Trends in Global Market
Table 2. IgA Nephropathy Drugs Market Drivers in Global Market
Table 3. IgA Nephropathy Drugs Market Restraints in Global Market
Table 4. Key Players of IgA Nephropathy Drugs in Global Market
Table 5. Top IgA Nephropathy Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global IgA Nephropathy Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global IgA Nephropathy Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies IgA Nephropathy Drugs Product Type
Table 9. List of Global Tier 1 IgA Nephropathy Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 IgA Nephropathy Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global IgA Nephropathy Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - IgA Nephropathy Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - IgA Nephropathy Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global IgA Nephropathy Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - IgA Nephropathy Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - IgA Nephropathy Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global IgA Nephropathy Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global IgA Nephropathy Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global IgA Nephropathy Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America IgA Nephropathy Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe IgA Nephropathy Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia IgA Nephropathy Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America IgA Nephropathy Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa IgA Nephropathy Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Calliditas Therapeutics Corporate Summary
Table 31. Calliditas Therapeutics IgA Nephropathy Drugs Product Offerings
Table 32. Calliditas Therapeutics IgA Nephropathy Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Travere Therapeutics Corporate Summary
Table 34. Travere Therapeutics IgA Nephropathy Drugs Product Offerings
Table 35. Travere Therapeutics IgA Nephropathy Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Omeros Corporation Corporate Summary
Table 37. Omeros Corporation IgA Nephropathy Drugs Product Offerings
Table 38. Omeros Corporation IgA Nephropathy Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Novartis International Corporate Summary
Table 40. Novartis International IgA Nephropathy Drugs Product Offerings
Table 41. Novartis International IgA Nephropathy Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Chinook Therapeutics Corporate Summary
Table 43. Chinook Therapeutics IgA Nephropathy Drugs Product Offerings
Table 44. Chinook Therapeutics IgA Nephropathy Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Vera Therapeutics Corporate Summary
Table 46. Vera Therapeutics IgA Nephropathy Drugs Product Offerings
Table 47. Vera Therapeutics IgA Nephropathy Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Otsuka Pharmaceutical Corporate Summary
Table 49. Otsuka Pharmaceutical IgA Nephropathy Drugs Product Offerings
Table 50. Otsuka Pharmaceutical IgA Nephropathy Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. IgA Nephropathy Drugs Segment by Type in 2021
Figure 2. IgA Nephropathy Drugs Segment by Application in 2021
Figure 3. Global IgA Nephropathy Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global IgA Nephropathy Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global IgA Nephropathy Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by IgA Nephropathy Drugs Revenue in 2021
Figure 8. By Type - Global IgA Nephropathy Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global IgA Nephropathy Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global IgA Nephropathy Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America IgA Nephropathy Drugs Revenue Market Share, 2017-2028
Figure 12. US IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe IgA Nephropathy Drugs Revenue Market Share, 2017-2028
Figure 16. Germany IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia IgA Nephropathy Drugs Revenue Market Share, 2017-2028
Figure 24. China IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America IgA Nephropathy Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa IgA Nephropathy Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE IgA Nephropathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Calliditas Therapeutics IgA Nephropathy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Travere Therapeutics IgA Nephropathy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Omeros Corporation IgA Nephropathy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis International IgA Nephropathy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Chinook Therapeutics IgA Nephropathy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Vera Therapeutics IgA Nephropathy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Otsuka Pharmaceutical IgA Nephropathy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE